Skip to main content

Table 1 Characteristics of women with and without premenstrual disorders (PMD)

From: Clinical indications of premenstrual disorders and subsequent risk of injury: a population-based cohort study in Sweden

 

Population cohort

Sibling cohort a

Reference N (%)

PMD N (%)

Reference N (%)

PMD N (%)

Total number

1,472,310

18,628

631,236

7,674

Year of birth

 1960–1964

239,959 (16.3)

4346 (23.3)

80,813 (12.8)

1471 (19.2)

 1965–1970

255,554 (17.4)

5080 (27.3)

111,933 (17.7)

2142 (27.9)

 1970–1974

243,458 (16.5)

4097 (22.0)

112,549 (17.8)

1837 (23.9)

 1975–1979

218,052 (14.8)

2428 (13.0)

103,626 (16.4)

1097 (14.3)

 1980–1984

216,518 (14.7)

1628 (8.7)

106,187 (16.8)

753 (9.8)

 1985–1990

298,769 (20.3)

1049 (5.6)

116,128 (18.4)

374 (4.9)

Educational level

 Primary

226,819 (15.4)

2304 (12.4)

104,799 (16.6)

957 (12.5)

 High school

604,802 (41.1)

9435 (50.6)

262,378 (41.6)

3910 (51.0)

 College and beyond

379,324 (25.8)

6005 (32.2)

166,447 (26.4)

2508 (32.7)

 Unknown

261,365 (17.8)

884 (4.7)

97,612 (15.5)

299 (3.9)

Region of residency

 South

342,159 (23.2)

3602 (19.3)

150,946 (23.9)

1514 (19.7)

 Middle

825,202 (56.0)

11,293 (60.6)

347,545 (55.1)

4597 (59.9)

 North

304,949 (20.7)

3733 (20.0)

132,745 (21.0)

1563 (20.4)

History of injury

 No

1,327,241 (90.1)

14,169 (76.1)

571,236 (90.5)

5870 (76.5)

 Yes

145,069 (9.9)

4459 (23.9)

60,000 (9.5)

1804 (23.5)

 

PYs (%)

PYs (%)

PYs (%)

PYs (%)

Psychiatric comorbiditiesb

 No

13,820,488 (95.6)

83,418 (89.3)

6,050,657 (95.9)

34,195 (89.7)

 Yes

636,709 (4.4)

10,005 (10.7)

261,787 (4.1)

3932 (10.3)

  1. N number, PYs person-years
  2. aSibling cohort was restricted to women with at least one identifiable full sister in the population cohort
  3. bPsychiatric disorder was considered as time-varying, i.e., person-years from the cohort entry if any diagnosis of psychiatric disorders occurred before cohort entry, or person-years from the date of diagnosis if any diagnosis of psychiatric disorders occurred during the follow-up